Xeris Biopharma (XERS) news
Recent news
Xeris Biopharma - Lawsuits filed against Torrent, Cycle, Lemed, Rising Pharma defendants - SEC filing
AInvest Wire · 5h agoXeris Biopharma - Files patent infringement lawsuits in U.S. district court - SEC filing
AInvest Wire · 5h agoOFCOM: Decided to focus the remainder of investigation on X's compliance with its illegal content and complaints and reporting duties
The UK's communications regulator, Ofcom, has announced that it will focus the remainder of its investigation on X's compliance with its obligations regarding illegal content and complaints and reporting duties. This decision follows an ongoing review of the platform's adherence to the Online…
AInvest Wire · 8h agoXeris Biopharma Holdings, Inc.: Barclays raises target price to $14 from $12
AInvest Wire · Oct 6, 2026Xeris Biopharma Holdings, Inc.: Jefferies raises target price to $12 from $10
Jefferies Financial Group analyst Glen Santangelo has raised his price target for Xeris Biopharma Holdings, Inc. (XERS) to $12 from $10, maintaining an Overweight rating for the stock . This adjustment reflects the firm’s confidence in Xeris’ recent performance and strategic progress. Xeris…
AInvest Wire · Oct 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.